290 related articles for article (PubMed ID: 27176825)
1. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.
Bi L; Wu J; Ye A; Wu J; Yu K; Zhang S; Han Y
J Transl Med; 2016 May; 14(1):132. PubMed ID: 27176825
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia.
Han Y; Ye A; Bi L; Wu J; Yu K; Zhang S
Cancer Sci; 2014 Aug; 105(8):933-42. PubMed ID: 24890519
[TBL] [Abstract][Full Text] [Related]
3. Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway.
Han J; Jin R; Zhang M; Guo Q; Zhou F
J Leukoc Biol; 2017 Mar; 101(3):675-681. PubMed ID: 27707884
[TBL] [Abstract][Full Text] [Related]
4. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis.
Truchetet ME; Allanore Y; Montanari E; Chizzolini C; Brembilla NC
Ann Rheum Dis; 2012 Dec; 71(12):2044-50. PubMed ID: 22814427
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
Li P; Shi X; Xu Y; Zhong B; Lu Y; Sun Y
Med Sci Monit; 2018 Nov; 24():7802-7808. PubMed ID: 30381753
[TBL] [Abstract][Full Text] [Related]
7. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
[TBL] [Abstract][Full Text] [Related]
8. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
10. Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels.
Zhong W; Zhu Z; Xu X; Zhang H; Xiong H; Li Q; Wei Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):73. PubMed ID: 30755239
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia.
Wang J; Xue HM; Chen YR; Xu HG; Lin SF; Tang XK; Chen C
J Pediatr Hematol Oncol; 2019 Mar; 41(2):96-104. PubMed ID: 30688831
[TBL] [Abstract][Full Text] [Related]
12. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
13. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
[TBL] [Abstract][Full Text] [Related]
14. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
[TBL] [Abstract][Full Text] [Related]
15. Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia.
Tian T; Sun Y; Li M; He N; Yuan C; Yu S; Wang M; Ji C; Ma D
Clin Chim Acta; 2013 Nov; 426():108-13. PubMed ID: 24064425
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
17. Regulatory effect of nicotine on the differentiation of Th1, Th2 and Th17 lymphocyte subsets in patients with rheumatoid arthritis.
Wu S; Zhou Y; Liu S; Zhang H; Luo H; Zuo X; Li T
Eur J Pharmacol; 2018 Jul; 831():38-45. PubMed ID: 29715455
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.
Eljaafari A; Tartelin ML; Aissaoui H; Chevrel G; Osta B; Lavocat F; Miossec P
Arthritis Rheum; 2012 Jul; 64(7):2147-57. PubMed ID: 22275154
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal modulation of helper Th1 and Th17 cells by the β2-adrenergic receptor agonist drug terbutaline.
Carvajal Gonczi CM; Tabatabaei Shafiei M; East A; Martire E; Maurice-Ventouris MHI; Darlington PJ
FEBS J; 2017 Sep; 284(18):3018-3028. PubMed ID: 28710773
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
